# Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

> **NCT02494713** · PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 4 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix
- **DRUG:** Doxorubicin
- **DRUG:** Ketoconazole
- **DRUG:** Docetaxel
- **DRUG:** Estramustine

## Key facts

- **NCT ID:** NCT02494713
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-09-14
- **Final completion:** 2017-09-14
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** slow enrollment; resource re-allocation
- **Last updated:** 2018-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494713, "Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02494713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*